Working together to improve health outcomes for our Aboriginal and Torres Strait Islander communities


PDC Health Hub

Last year, PDC Health Hub became the pioneering Perth Metro site for a ground breaking Flash Glucose Monitoring study aimed at transforming diabetes care for Indigenous Australians. As the first and (currently) only Perth Metro site, we're proud that our reach extends throughout the South West of WA, addressing a critical need in our community.

Aboriginal and Torres Strait Islander people are almost four times more likely than non-Indigenous Australians to have diabetes or pre-diabetes. This community is five times more likely to be admitted to the hospital with complications stemming from this condition. Recognising the urgent need for innovative solutions, we have joined the national randomised controlled trial which is focused on improving health outcomes for Indigenous Australians living with Type 2 diabetes.

Traditionally, monitoring blood glucose levels involves frequent finger-pricking tests, which can be intrusive and cumbersome. However, this study seeks to revolutionise this approach by exploring the efficacy of Flash Glucose Monitoring devices. These devices, which are designed to sit discreetly on the arm, provide continuous glucose monitoring, offering real-time insights into blood sugar levels without the need for constant finger pricking.

The potential benefits are immense. By providing individuals and their healthcare professionals with continuous glucose data, we aim to empower our clients to make informed decisions about their health. Identifying behavioural patterns that impact glucose levels becomes more accessible, paving the way for personalised and effective diabetes management strategies.

Led by Professor Elif Ekinci, Director of the Australian Centre for Accelerating Diabetes Innovations (ACADI) at the University of Melbourne, this study hopes to pave the way forward for better outcomes for our Indigenous communities. Participants will be randomly assigned to either use a Flash Glucose Monitor or adhere to standard care (finger pricking) for six months. However, regardless of how they are assigned, they all receive access to 6 months' worth of Flash Glucose Monitoring (those who are assigned to "standard care" receive their sensors at the conclusion of their time in the study).

The anticipated outcomes are huge. We expect to see lower HbA1c levels, achieving blood glucose targets, fewer low blood sugar episodes, reduced healthcare system costs, and improved quality of life among participants using Flash Glucose Monitoring. Moreover, by demonstrating the efficacy of this technology in Indigenous populations, we aim to use this to continue to advocate for its subsidisation, ensuring equitable access for our Indigenous communities.

Our commitment extends beyond research; it's about driving tangible change in health outcomes for Indigenous Australians. By leveraging cutting-edge technology and evidence-based interventions, we aspire to not only improve individual well-being but also enhance health service delivery for Indigenous and other high-risk populations across Australia.

This trial marks a pivotal moment in diabetes care, offering hope, empowerment, and the promise of a brighter, healthier future for Indigenous Australians. Together, let's work towards a healthier, more equitable tomorrow. Together, we can make a difference.

If you'd like to find out if you can participate, or you have clients who may be eligible, don't hesitate to reach out to our friendly client liaison team via email admin@pdchealthhub.com.au or 08 6110 0570.

Related Blogs